(Q51821980)

English

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

scientific article published on 11 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

psoriatic arthritis

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Arthur Kavanaugh

9

object named as

Arthur Kavanaugh

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

author name string

Alice Gottlieb

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Alan Menter

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Alan Mendelsohn

3

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Yaung-Kaung Shen

4

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Shu Li

5

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Cynthia Guzzo

6

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Scott Fretzin

7

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Rod Kunynetz

8

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

language of work or name

0 references

publication date

11 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

373

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

9664

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

633-640

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Epidemiology of psoriatic arthritis in the population of the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960140-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)60140-9

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19217154

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51821980&oldid=1935719311"